Blog - Page 3029 of 5692

ThursdayMay 16, 2013 12:25 pm

Rafarma Pharmaceuticals, Inc. (RAFA) Continues to Build Drug Pipeline

Rafarma Pharmaceuticals is one of Russia’s newest and most promising pharmaceutical companies. A company whose development and growth is being actively encouraged by the government, in a move to lessen Russian dependence upon western pharmaceutical companies for widely used pharmaceuticals, Rafarma is currently specializing in the production of generic antibiotics, but has a growing pipeline of other drugs, including proprietary products already approved. The company expects significant near-term results with its line of current and researched pharmaceuticals, including the following group of antibiotics. • Benzalconium Fluoride - Open randomized study of the efficacy and safety of the drug “benzalkonium fluoride,…

ThursdayMay 16, 2013 12:22 pm

Northwest Biotherapeutics, Inc. (NWBO) Begins Phase III Trial of DCVax-L for Brain Cancer

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products for the American and European markets to treat cancers more effectively than current treatments, while costing less, and without the toxicities associated chemotherapies. It is currently working on the DCVax-L personalized immune therapies for solid tumor cancers. The company announced today that its Phase III clinical trial with DCVax-L for brain cancer has begun at King's College Hospital in the U.K., a major European center for neuro-oncology. Other sites across Europe, including three more in the U.K. and nearly 20 in Germany, are in varying stages of preparations for…

ThursdayMay 16, 2013 9:06 am

Trio Resources, Inc. (TRII) Reports Q2 2013 Financial Results, Achieves First Revenues

Trio Resources, an exploration and small-scale processing company reported financial results for the second quarter ended March 31, 2013, marking the first revenues recorded since the company’s inception in May, 2012. The company also recapped its first-quarter achievements, including its five-year off-take agreement with United Commodity AG. "During the first quarter, we continued to distinguish ourselves from other junior mining companies by executing on our strategy to monetize our significant stockpiles of mineralized materials and securing a five year off-take agreement with United Commodity AG, one of the world's leading processors of precious metals," Duncan Reid, CEO of Trio Resources…

ThursdayMay 16, 2013 9:02 am

eMagin Corp. (EMAN) to Introduce World’s Brightest Full Color OLED Microdisplays

eMagin, a leader in OLED microdisplay technology, OLED microdisplay manufacturing know-how, and mobile display systems, announced yesterday that it has developed the world’s brightest family of super bright, energy efficient, and full color organic light emitting diode (OLED) microdisplays, called the Color OLED-XLS™. At 1000 nits of luminance, the Color OLED-XLS™ blows away the industry standard for brightness four times over. This new display is fully compatible with eMargin’s entire VGA, SVGA, SXGA, and WUXGA, and only requires half of the power of the company’s current color displays at the same brightness. This breakthrough display technology enables a much broader…

WednesdayMay 15, 2013 1:51 pm

VistaGen Therapeutics, Inc. (VSTA) Continues to Move Forward with Revolutionary Drug Testing Technology

VistaGen is a biotech company focused on using stem cell technology to generate new, safer variants (drug rescue variants) of once-promising small molecule drug candidates that were developed but ultimately discontinued by large pharmaceutical companies due to heart or liver toxicity issues. VistaGen aims to use their proprietary stem cell technology as a previously unavailable cost effective way to re-examine and ultimately “rescue” such lost drugs, thereby recovering the value from what is usually a substantial prior investment in research and development. The company recognizes the drug discovery and development crisis facing the U.S. pharmaceutical industry, where increasingly big investments…

WednesdayMay 15, 2013 1:39 pm

Golden Cross Resources, Inc. (CNSX:GOX), Blue Gold Tailing Technologies Ltd. Focus on Innovative Water Purification Solutions

Blue Gold Tailing Technologies is a water remediation company focusing on transforming contaminated waters into pure, safe, drinkable water. The company’s environmentally safe solutions address global water purification, restoration, and contamination issues, adhering to EPA guidelines as to what constitutes safe agricultural or drinkable water. Blue Gold then tailors these guidelines to acceptable standards in the jurisdiction in which the technology is used. This technology can also be used to recover heavy and precious metals from mine tailings. Privately held Blue Gold is currently undergoing acquisition by Golden Cross Resources via merger with Golden Cross’ Ontario subsidiary. The emerging company…

WednesdayMay 15, 2013 12:31 pm

The Guitammer Company, Inc. (GTMM) Reports Q1 2013 Financial Results and Highlights

The Guitammer Company, a leader in low frequency sound and creator of the award-winning line of ButtKicker®-brand low frequency audio transducers that provide an immersive entertainment experience for audiences, just announced its results for the first quarter ended March 31, 2013. The company featured the following financial highlights and recent developments: • Net loss decreased by 6% for the three months ended March 31, 2013 compared to the three months ended March 31, 2012. • Total current assets increased 5.9%, or $51,034, to approximately $912,000, as of March 31, 2013 compared to March 31, 2012, attributed primarily to the increase…

WednesdayMay 15, 2013 12:13 pm

Brekford Corp. (BFDI) Wins Contract with the City of Asheville, North Carolina

Brekford has been a public safety technology and services solutions partner to public sector agencies at the local, state, and federal level for over ten years. The company's range of solutions include automated traffic enforcement programs, delinquent municipal receivables processing and collection, turnkey law enforcement vehicle upfitting services, and a suite of mobile computer and video technology products. The company announced today that it won a three-year contract with the city of Asheville, North Carolina, for the provision of parking citation issuance, processing, and delinquent collections. The contract includes the provision of wireless handheld enforcement devices, web-based parking citation processing…

WednesdayMay 15, 2013 12:10 pm

Enrollment Completed for European Clinical Trial of Cardica, Inc. (CRDC) MicroCutter XCHANGE 30

Cardica announced the completion of enrollment for the European clinical study of its MicroCutter XCHANGE 30, which is a cartridge-based cutting/stapling device with a 5-millimeter shaft diameter and a cross-sectional area that is more than six times smaller than the standard 12-millimeter surgical staplers currently in use. The trial has been created to evaluate the XCHANGE 30’s safety in various gastrointestinal surgical procedures in support of a 510(k) filing for market clearance from the FDA. The company expects to file regulatory documents with the FDA in the third quarter of calendar 2013, based on consistent product performance and positive unaudited…

WednesdayMay 15, 2013 12:03 pm

First Independence Corp. (FICF) Codesmart University™ ICD Courses Approved for CEU Credits by Top Medical Coding Associations

First Independence Corp. and its subsidiary, The Codesmart™ Group, an ICD-10 education and solutions group, reported that its Codesmart™ University study programs are now eligible for Continuing Education Units (CEU) for existing medical coders, as certified by the Association of Professional Coders (APPC) and the American Health Information Management Association (AHIMA). ICD-10, or the tenth revision of the International Classification of Diseases, is approved by the World Health Organization for the designation of the aspects of disease treatment that include categories of diseases and treatment modalities for them. This tenth revision of the ICD has been broken down into more…

Site Search

Company Search